Trial design for cancer (cell)-specific anticancer therapies

RJ (Robbert) van Alphen, Jaap Verweij, Ferry Eskens

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1137-1141
Number of pages	5
Journal	Expert Opinion on Therapeutic Targets
Volume	11
Issue number	9
DOIs	https://doi.org/10.1517/14728222.11.9.1137
Publication status	Published - 2007

Research programs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{6f71c5a773c74094bd819a72c8898351,

title = "Trial design for cancer (cell)-specific anticancer therapies",

author = "{van Alphen}, {RJ (Robbert)} and Jaap Verweij and Ferry Eskens",

year = "2007",

doi = "10.1517/14728222.11.9.1137",

language = "Undefined/Unknown",

volume = "11",

pages = "1137--1141",

journal = "Expert Opinion on Therapeutic Targets",

issn = "1472-8222",

publisher = "Taylor & Francis Ltd",

number = "9",

}

TY - JOUR

T1 - Trial design for cancer (cell)-specific anticancer therapies

AU - van Alphen, RJ (Robbert)

AU - Verweij, Jaap

AU - Eskens, Ferry

PY - 2007

Y1 - 2007

U2 - 10.1517/14728222.11.9.1137

DO - 10.1517/14728222.11.9.1137

M3 - Article

C2 - 17845141

SN - 1472-8222

VL - 11

SP - 1137

EP - 1141

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

IS - 9

ER -